| BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases T Pal, J Permuth‐Wey, JA Betts, JP Krischer, J Fiorica, H Arango, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2005 | 1005 | 2005 |
| A population-based study of genes previously implicated in breast cancer C Hu, SN Hart, R Gnanaolivu, H Huang, KY Lee, J Na, C Gao, J Lilyquist, ... New England Journal of Medicine 384 (5), 440-451, 2021 | 967 | 2021 |
| Genetic/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN clinical practice guidelines in oncology MB Daly, T Pal, MP Berry, SS Buys, P Dickson, SM Domchek, ... Journal of the National Comprehensive Cancer Network 19 (1), 77-102, 2021 | 964 | 2021 |
| BRCA1-and BRCA2-associated hereditary breast and ovarian cancer N Petrucelli, MB Daly, T Pal | 850 | 2022 |
| NCCN guidelines insights: genetic/familial high-risk assessment: breast and ovarian, version 2.2017 MB Daly, R Pilarski, M Berry, SS Buys, M Farmer, S Friedman, JE Garber, ... Journal of the National Comprehensive Cancer Network 15 (1), 9-20, 2017 | 543 | 2017 |
| Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families X Yang, G Leslie, A Doroszuk, S Schneider, J Allen, B Decker, ... Journal of clinical oncology 38 (7), 674-685, 2020 | 510 | 2020 |
| NCCN guidelines insights: genetic/familial high-risk assessment: breast, ovarian, and pancreatic, version 1.2020: featured updates to the NCCN guidelines MB Daly, R Pilarski, MB Yurgelun, MP Berry, SS Buys, P Dickson, ... Journal of the National Comprehensive Cancer Network 18 (4), 380-391, 2020 | 434 | 2020 |
| Genetic/familial high-risk assessment: breast and ovarian MB Daly, JE Axilbund, S Buys, B Crawford, CD Farrell, S Friedman, ... Journal of the National Comprehensive Cancer Network 8 (5), 562-594, 2010 | 365 | 2010 |
| Racial disparities in BRCA testing and cancer risk management across a population‐based sample of young breast cancer survivors D Cragun, A Weidner, C Lewis, D Bonner, J Kim, ST Vadaparampil, T Pal Cancer 123 (13), 2497-2505, 2017 | 309 | 2017 |
| NCCN Guidelines® insights: genetic/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2024: featured updates to the NCCN guidelines MB Daly, T Pal, KN Maxwell, J Churpek, W Kohlmann, Z AlHilli, B Arun, ... Journal of the National Comprehensive Cancer Network 21 (10), 1000-1010, 2023 | 252 | 2023 |
| BRCA1 and BRCA2 genetic testing—pitfalls and recommendations for managing variants of uncertain clinical significance DM Eccles, G Mitchell, ANA Monteiro, R Schmutzler, FJ Couch, ... Annals of oncology 26 (10), 2057-2065, 2015 | 241 | 2015 |
| Increased risk for nonmedullary thyroid cancer in the first degree relatives of prevalent cases of nonmedullary thyroid cancer: a hospital-based study T Pal, FD Vogl, PO Chappuis, R Tsang, J Brierley, H Renard, K Sanders, ... The Journal of Clinical Endocrinology & Metabolism 86 (11), 5307-5312, 2001 | 225 | 2001 |
| Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers J Kotsopoulos, T Huzarski, J Gronwald, CF Singer, P Moller, HT Lynch, ... Journal of the National Cancer Institute 109 (1), djw177, 2017 | 223 | 2017 |
| Overall mortality after diagnosis of breast cancer in men vs women F Wang, X Shu, I Meszoely, T Pal, IA Mayer, Z Yu, W Zheng, CE Bailey, ... JAMA oncology 5 (11), 1589-1596, 2019 | 218 | 2019 |
| Genetic/familial high-risk assessment: breast and ovarian, version 2.2015 MB Daly, R Pilarski, JE Axilbund, M Berry, SS Buys, B Crawford, M Farmer, ... Journal of the National Comprehensive Cancer Network 14 (2), 153-162, 2016 | 211 | 2016 |
| Long-term ovarian cancer survival associated with mutation in BRCA1 or BRCA2 JR McLaughlin, B Rosen, J Moody, T Pal, I Fan, PA Shaw, HA Risch, ... Journal of the National Cancer Institute 105 (2), 141-148, 2013 | 206 | 2013 |
| International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation K Metcalfe, A Eisen, L Senter, S Armel, L Bordeleau, WS Meschino, T Pal, ... British journal of cancer 121 (1), 15-21, 2019 | 187 | 2019 |
| Systematic review and meta-analysis of ovarian cancers: estimation of microsatellite-high frequency and characterization of mismatch repair deficient tumor histology T Pal, J Permuth-Wey, A Kumar, TA Sellers Clinical Cancer Research 14 (21), 6847-6854, 2008 | 174 | 2008 |
| GeneReviews N Petrucelli, MB Daly, T Pal, MP Adam, HH Ardinger, RA Pagon, ... University of Washington, 1993 | 167 | 1993 |
| A review of the clinical relevance of mismatch‐repair deficiency in ovarian cancer T Pal, J Permuth‐Wey, TA Sellers Cancer: Interdisciplinary International Journal of the American Cancer …, 2008 | 153 | 2008 |
Steven NarodCanada Research Chair in Breast Cancer; Director, Familial Breast Cancer Research Unit, WCRIVerified email at wchospital.ca
